Glycogenic hepatopathy associated with hepatic steatosis in type 1 diabetes

被引:0
作者
Teasdale, Stephanie [1 ]
Dong, Xin [2 ]
Griffin, Alison [3 ]
Clark, Paul James [4 ]
Nisbet, Janelle [1 ]
Morton, Adam [1 ]
Phillips, Liza [1 ]
Sullivan, Mitchell Anthony [5 ]
Galloway, Graham [2 ]
机构
[1] Mater Hosp Brisbane, Queensland Diabet & Endocrine Ctr, South Brisbane, Qld, Australia
[2] Translat Res Inst, Woolloongabba, Australia
[3] QIMR Berghofer Med Res Inst, Herston, Qld, Australia
[4] Mater Hosp Brisbane, Gastroenterol unit, South Brisbane, Australia
[5] Univ Queensland, Mater Res Inst, TRI, Brisbane, Qld, Australia
关键词
Type; 1; diabetes; Glycogenic hepatopathy; Hepatomegaly; Hepatic steatosis; Imaging; FATTY LIVER-DISEASE; MAURIAC-SYNDROME; SPECTROSCOPY; INSULIN; MUSCLE;
D O I
10.1016/j.jdiacomp.2024.108870
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Glycogenic hepatopathy is associated with significant psychosocial consequences and health costs. Metabolic Dysfunction-Associated Steatotic Liver Disease and glycogenic hepatopathy are frequently confused as "fatty liver" when seen on ultrasonography. We wished to examine liver fat and glycogen content in groups defined based on metabolic and liver disease phenotypes. Methods: This case-control study undertaken in a tertiary hospital used nuclear proton magnetic resonance spectroscopy (H-1-MRS) to examine liver fat and glycogen content in five clinical groups, each containing five participants: 1. type 1 diabetes with glycogenic hepatopathy, 2. satisfactorily controlled type 1 diabetes with no liver disease, 3. poorly controlled type 1 diabetes without liver disease, 4. a control group of body mass index- and age-matched individuals without diabetes or liver disease, and 5. hepatic steatosis. Results: Fat content was highest in the hepatic steatosis (median 15.4 %, IQR 10.0-19.3) and glycogenic hepatopathy (median 6.5 %, IQR 4.5-9.1) groups and compared to both of these groups was lower in the control group (median 1.0 %, IQR 0.7-1.1, p 0.002 and 0.022), the T1DM group with satisfactory control (median 0.3 %, IQR 0.2-0.6, p < 0.001 and <0.001), and the T1DM group with poor control without liver disease (median 1.1 %, IQR 0.9-1.1, p 0.001 and 0.012). No participants from the type 1 diabetes poor control, type 1 diabetes satisfactory control or the no diabetes groups had H-1-MRS-diagnosed hepatic steatosis. H-1-MRS glycogen content could not be interpreted in the majority of those with glycogenic hepatopathy because of interference from the fat signal. Conclusions: In cases diagnosed with glycogenic hepatopathy there may be significant concomitant fat accumulation, compounding the already elevated cardiovascular risk in this cohort. The technique of H-1-MRS has not been demonstrated to be useful for diagnosing glycogenic hepatopathy.
引用
收藏
页数:7
相关论文
共 32 条
  • [1] Elevated Lactate Levels in Patients With Poorly Regulated Type 1 Diabetes and Glycogenic Hepatopathy: A New Feature of Mauriac Syndrome
    Brouwers, Martijn C. G. J.
    Ham, Janneke C.
    Wisse, Eddie
    Misra, Shivani
    Landewe, Sabine
    Rosenthal, Miranda
    Patel, Dipesh
    Oliver, Nick
    Bilo, Henk J. G.
    Murphy, Elaine
    [J]. DIABETES CARE, 2015, 38 (02) : E11 - E12
  • [2] PROTON NMR OBSERVATION OF GLYCOGEN IN-VIVO
    CHEN, W
    AVISON, MJ
    BLOCH, G
    SHULMAN, RG
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1994, 31 (05) : 576 - 579
  • [3] Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy
    Duarte, IF
    Stanley, EG
    Holmes, E
    Lindon, JC
    Gil, AM
    Tang, HR
    Ferdinand, R
    McKee, CG
    Nicholson, JK
    Vilca-Melendez, H
    Heaton, N
    Murphy, GM
    [J]. ANALYTICAL CHEMISTRY, 2005, 77 (17) : 5570 - 5578
  • [4] Elder CJ, 2010, J PEDIATR ENDOCR MET, V23, P311
  • [5] Relationship between muscle water and glycogen recovery after prolonged exercise in the heat in humans
    Fernandez-Elias, Valentin E.
    Ortega, Juan F.
    Nelson, Rachael K.
    Mora-Rodriguez, Ricardo
    [J]. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2015, 115 (09) : 1919 - 1926
  • [6] Hepatopathy of Mauriac syndrome: a retrospective review from a tertiary liver centre
    Fitzpatrick, E.
    Cotoi, C.
    Quaglia, A.
    Sakellariou, S.
    Ford-Adams, M. E.
    Hadzic, N.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2014, 99 (04) : 354 - 357
  • [7] Focal Hepatic Glycogenosis in a Patient With Uncontrolled Diabetes Mellitus Type 1
    Glushko, Tetiana
    Kushchayev, Sergiy V.
    Trifanov, Dmitry
    Salei, Aliaksei
    Morales, Diego
    Berry, Gerard
    Mackey, Justin
    Teytelboym, Oleg M.
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2018, 42 (02) : 230 - 235
  • [8] Quantification of Liver Fat Content: Comparison of Triple-Echo Chemical Shift Gradient-Echo Imaging and in Vivo Proton MR Spectroscopy
    Guiu, Boris
    Petit, Jean-Michel
    Loffroy, Romaric
    Salem, Douraied Ben
    Aho, Serge
    Masson, David
    Hillon, Patrick
    Krause, Denis
    Cercueil, Jean-Pierre
    [J]. RADIOLOGY, 2009, 250 (01) : 95 - 102
  • [9] Diurnal variation in the glycogen content of the human liver using 13C MRS
    Iwayama, Kaito
    Onishi, Takahiro
    Maruyama, Katsuya
    Takahashi, Hideyuki
    [J]. NMR IN BIOMEDICINE, 2020, 33 (06)
  • [10] Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders
    Johnson, Nathan A.
    Walton, David W.
    Sachinwalla, Toos
    Thompson, Campbell H.
    Smith, Kate
    Ruell, Patricia A.
    Stannard, Stephen R.
    George, Jacob
    [J]. HEPATOLOGY, 2008, 47 (05) : 1513 - 1523